Nuclear News on the Newswire

Senate passes nuclear ADVANCE Act; bill heads to Biden

The U.S. Senate yesterday passed the Accelerating Deployment of Versatile, Advanced Nuclear for Clean Energy (ADVANCE) Act, sending legislation that would make sweeping changes to the approval process for new technology in the nuclear energy sector to President Biden for final approval.

The legislation passed with an overwhelming majority in the Senate—the vote was 88–2—having cleared the House of Representatives in May.

Go to Article

Zeno looks to SHINE for Sr-90 to fuel its radioisotope power systems

Wisconsin-based fusion technology company SHINE Technologies announced today the signing of a memorandum of understanding with Zeno Power to develop a nuclear materials supply chain for its commercially available radioisotope power systems (RPSs). Under the MOU, SHINE plans to provide Zeno with strontium-90 to power its RPSs, which are capable of providing continuous power in harsh environments.

Go to Article

Orano Med inaugurates Pb-212 production facility in Indiana

Guillaume Dureau of Orano Group (left) and Orano Med’s Julien Dodet cut the ribbon on the new ATLabs Indianapolis. (Photo: Orano)

Orano Group subsidiary Orano Med, a developer of targeted alpha therapies for oncology, inaugurated its first ATLab (Alpha Therapy Laboratory) earlier this month. Located in Brownsburg, near Indianapolis, Ind., ATLab Indianapolis is an industrial-scale pharmaceutical facility dedicated to the production of lead-212–based radioligand therapies.

Targeted alpha therapy has shown to be effective in treating various oncological diseases, combining the natural ability of biological molecules to target cancer cells with the short-range cell-killing capabilities of alpha emissions generated by Pb-212. With a half-life of 10.64 hours, along with a decay product of the short-lived alpha-emitter bismuth-212, Pb-212 allows for the possible synthesis and purification of complex radiopharmaceuticals with minimum loss of radioactivity during preparation.

The development of radiopharmaceuticals has long been hampered by the difficulty of manufacturing and distribution on an industrial scale, Orano said, adding that the construction of ATLab Indianapolis is a major step toward making these new treatments available to cancer patients with high unmet needs in North America.

Go to Article

Annual Conference opening plenary: Full speed ahead

The 2024 American Nuclear Society Annual Conference opened with a bang yesterday as 1,200 attendees gathered in Las Vegas to network, collaborate, and socialize. Honors and awards were presented to several recipients, and ANS welcomed twelve new Fellows.

The plenary opened with an address from ANS Executive Director/Chief Executive Officer Craig Piercy that brought this year’s theme to the fore straight away: The time is now to deploy new nuclear projects—and not acting at this moment is simply not an option.

Go to Article

Senate confirms 3 FERC appointees

The U.S. Senate voted last week to put three new members on the Federal Energy Regulatory Commission, a bipartisan energy oversight board.

The chamber confirmed the nominations of Republican Lindsay See and Democrats David Rosner and Judy Chang. The votes on the nominations were 86–9, 68–26 and 63–33, respectively.

Go to Article

Join Trustees of Nuclear to support key ANS initiatives

The ANS Trustees of Nuclear corporate membership program invites nuclear industry companies and suppliers to join ANS in support of the Society’s K-12 STEM initiatives, the Rapid Response Taskforce, and Nuclear Policy Leadership Events. Below are summaries of the three programs supported by the Trustees of Nuclear.

Go to Article

Wyoming as a hub for the nuclear supply chain?

A 60-year-old Wyoming industrial machinery company has joined forces with nuclear innovator BWX Technologies to build and deploy 50-megawatt microreactors in America’s heartland over the coming years to provide carbon-free heat and power for industrial users.

Go to Article

Company touts efficiency of coin cell nuclear battery

Infinity Power has developed a nuclear battery that it says generates electrical power from radioisotopes with 60 percent overall efficiency, exceeding that of other radioisotope energy conversion methods, which are typically less than 10 percent. The company believes its technology—developed in part under contracts from the Department of Defense—has potential for “next-generation radioisotope power sources.”

Go to Article